INTRODUCTION: Fibrinogen is a key component of the blood coagulation system and plays important, diverse roles in several relevant pathologies such as thrombosis, hemorrhage, and cancer. It is a large glycoprotein whose three-dimensional molecular structure is not fully known. Furthermore, circulating fibrinogen is highly heterogeneous, mainly due to proteolytic degradation and alternative mRNA processing. Recombinant production of human fibrinogen allows investigating the impact on the three-dimensional structure of specific changes in the primary structure. METHODS: We performed analytical ultracentrifugation analyses of a full-length recombinant human fibrinogen, its counterpart purified from human plasma, and a recombinant human fibrinogen with both Aα chains truncated at amino acid 251, thus missing their last 359 amino acid residues. RESULTS: We have accurately determined the translational diffusion and sedimentation coefficients (Dt(20,w)(0), s(20,w)(0)) of all three species. This was confirmed by derived molecular weights within 1% for the full length species, and 5% for the truncated species, as assessed by comparison with SDS-PAGE/Western blot analyses and primary structure data. No significant differences in the values of Dt(20,w)(0) and s(20,w)(0) were found between the recombinant and purified full length human fibrinogens, while slightly lower and higher values, respectively, resulted for the recombinant truncated human fibrinogen compared to a previously characterized purified human fibrinogen fragment X obtained by plasmin digestion. CONCLUSIONS: Full-length recombinant fibrinogen is less polydisperse but hydrodynamically indistinguishable from its counterpart purified from human plasma. Recombinant Aα251-truncated human fibrinogen instead behaves differently from fragment X, suggesting a role for the Bβ residues 1-52 in inter-molecular interactions. Overall, these new hydrodynamic data will constitute a reliable benchmark against which models of fibrinogen species could be compared.
INTRODUCTION:Fibrinogen is a key component of the blood coagulation system and plays important, diverse roles in several relevant pathologies such as thrombosis, hemorrhage, and cancer. It is a large glycoprotein whose three-dimensional molecular structure is not fully known. Furthermore, circulating fibrinogen is highly heterogeneous, mainly due to proteolytic degradation and alternative mRNA processing. Recombinant production of humanfibrinogen allows investigating the impact on the three-dimensional structure of specific changes in the primary structure. METHODS: We performed analytical ultracentrifugation analyses of a full-length recombinant humanfibrinogen, its counterpart purified from human plasma, and a recombinant humanfibrinogen with both Aα chains truncated at amino acid 251, thus missing their last 359 amino acid residues. RESULTS: We have accurately determined the translational diffusion and sedimentation coefficients (Dt(20,w)(0), s(20,w)(0)) of all three species. This was confirmed by derived molecular weights within 1% for the full length species, and 5% for the truncated species, as assessed by comparison with SDS-PAGE/Western blot analyses and primary structure data. No significant differences in the values of Dt(20,w)(0) and s(20,w)(0) were found between the recombinant and purified full length human fibrinogens, while slightly lower and higher values, respectively, resulted for the recombinant truncated humanfibrinogen compared to a previously characterized purified humanfibrinogen fragment X obtained by plasmin digestion. CONCLUSIONS: Full-length recombinant fibrinogen is less polydisperse but hydrodynamically indistinguishable from its counterpart purified from human plasma. Recombinant Aα251-truncated humanfibrinogen instead behaves differently from fragment X, suggesting a role for the Bβ residues 1-52 in inter-molecular interactions. Overall, these new hydrodynamic data will constitute a reliable benchmark against which models of fibrinogen species could be compared.
Authors: Rustem I Litvinov; Sergiy Yakovlev; Galina Tsurupa; Oleg V Gorkun; Leonid Medved; John W Weisel Journal: Biochemistry Date: 2007-07-13 Impact factor: 3.162
Authors: Justin M Kollman; Leela Pandi; Michael R Sawaya; Marcia Riley; Russell F Doolittle Journal: Biochemistry Date: 2009-05-12 Impact factor: 3.162
Authors: Barbara Cardinali; Aldo Profumo; Anna Aprile; Olwyn Byron; Gordon Morris; Stephen E Harding; Walter F Stafford; Mattia Rocco Journal: Arch Biochem Biophys Date: 2009-10-22 Impact factor: 4.013
Authors: Galina Tsurupa; Roy R Hantgan; Robert A Burton; Igor Pechik; Nico Tjandra; Leonid Medved Journal: Biochemistry Date: 2009-12-29 Impact factor: 3.162
Authors: René P Zahedi; Urs Lewandrowski; Julia Wiesner; Stefanie Wortelkamp; Jan Moebius; Claudia Schütz; Ulrich Walter; Stepan Gambaryan; Albert Sickmann Journal: J Proteome Res Date: 2007-12-19 Impact factor: 4.466
Authors: Anna D Protopopova; Rustem I Litvinov; Dennis K Galanakis; Chandrasekaran Nagaswami; Nikolay A Barinov; Alexander R Mukhitov; Dmitry V Klinov; John W Weisel Journal: Nanoscale Date: 2017-09-21 Impact factor: 7.790